For some reason I can't reply to your post @contraindicator
"Sprott calls it $260 mill usd too."
I think we're talking on crossed paths here.I'm talking about what it cost Ganfeng for their 50% of the project, not the value of the project.
That's my point, the project is worth multiples of the US$65 they effectively paid.
Thats good for them, the deal is also very good for us.
It's a win win situation.
- Forums
- ASX - By Stock
- FFX
- Ann: Joint Venture with Ganfeng - Overview
Ann: Joint Venture with Ganfeng - Overview, page-78
-
- There are more pages in this discussion • 113 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online